Androgenic-anabolic steroids: the new insidious killer leading to heart failure

Minerva Cardioangiol. 2017 Dec;65(6):663-666. doi: 10.23736/S0026-4725.17.04396-1.

Authors

Maria V Polito¹, Santo Dellegrottaglie², Rosanna Matturro³, Domenico Bonadies⁴, Roberta DE Rosa⁵, Gennaro Galasso³

Affiliations

¹ Department of Medicine and Surgery, University of Salerno, Salerno, Italy - mvpolito@hotmail.it.
² Division of Cardiology, Villa dei Fiori Hospital, Acerra, Naples, Italy.
³ Department of Medicine and Surgery, University of Salerno, Salerno, Italy.
⁴ Department of Cardiology, A.O.U. "San Giovanni di Dio e Ruggi D'Aragona", Salerno, Italy.
⁵ Department of Cardiology, J.W. Goethe University Hospital of Frankfurt, Frankfurt, Germany.

PMID: 28971665
DOI: 10.23736/S0026-4725.17.04396-1

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anabolic Agents / adverse effects*
Cardiomyopathy, Dilated / chemically induced
Cardiomyopathy, Dilated / diagnostic imaging
Cardiomyopathy, Dilated / therapy
Heart Failure / chemically induced*
Heart Failure / diagnostic imaging
Heart Failure / therapy
Humans
Male
Steroids / adverse effects*
Substance-Related Disorders / complications
Testosterone Congeners / adverse effects*

Substances

Anabolic Agents
Steroids
Testosterone Congeners